Kingfisher Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-122,967
Closed -$4.13M 183
2021
Q4
$4.13M Buy
122,967
+6,400
+5% +$199K 0.95% 34
2021
Q3
$3.39M Buy
116,567
+2,563
+2% +$83K 0.88% 40
2021
Q2
$3.97M Buy
114,004
+6,093
+6% +$202K 1.01% 30
2021
Q1
$3.01M Buy
+107,911
New +$2.87M 0.84% 43

Other funds holding CC

Kingfisher Capital's CC Position: Q1 2022 in Review

Kingfisher Capital sold out of Chemours (CC) in Q1 2022, closing a stake of 122,967 shares — an estimated $4.13M sold.

Kingfisher Capital first reported a position in CC in Q1 2021 and held it in 4 quarters. The position peaked at $4.13M in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

  • Kingfisher Capital reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
  • Kingfisher Capital sold 122,967 Chemours shares in Q1 2022, an estimated $4.13M.
  • Kingfisher Capital first reported a position in Chemours in Q1 2021 and held it in 4 quarters.
  • Kingfisher Capital's Chemours position peaked at $4.13M in Q4 2021.
  • 481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Kingfisher Capital's 13F filing for Q1 2022, filed 10 May 2022.